0001527613 false Q1 2022 --09-30
0001527613 2021-10-01 2021-12-31 0001527613 2022-02-04 0001527613
2021-12-31 0001527613 2021-09-30 0001527613 2020-10-01 2020-12-31
0001527613 us-gaap:CommonStockMember 2021-09-30 0001527613
us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001527613
us-gaap:RetainedEarningsMember 2021-09-30 0001527613
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30
0001527613 us-gaap:CommonStockMember 2020-09-30 0001527613
us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001527613
us-gaap:RetainedEarningsMember 2020-09-30 0001527613
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30
0001527613 2020-09-30 0001527613 us-gaap:CommonStockMember
2021-10-01 2021-12-31 0001527613
us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31
0001527613 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31
0001527613 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-10-01 2021-12-31 0001527613 us-gaap:CommonStockMember
2020-10-01 2020-12-31 0001527613
us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31
0001527613 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31
0001527613 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-10-01 2020-12-31 0001527613 us-gaap:CommonStockMember
2021-12-31 0001527613 us-gaap:AdditionalPaidInCapitalMember
2021-12-31 0001527613 us-gaap:RetainedEarningsMember 2021-12-31
0001527613 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31 0001527613 us-gaap:CommonStockMember 2020-12-31
0001527613 us-gaap:AdditionalPaidInCapitalMember 2020-12-31
0001527613 us-gaap:RetainedEarningsMember 2020-12-31 0001527613
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31
0001527613 2020-12-31 0001527613 country:CA 2021-10-01 2021-12-31
0001527613 country:KR 2021-10-01 2021-12-31 0001527613
NUZE:LeaseAgreementMember NUZE:AllianceFundingGroupMember
2019-10-09 0001527613 NUZE:LeaseAgreementMember
NUZE:AllianceFundingGroupMember 2019-10-06 2019-10-09 0001527613
us-gaap:GeneralAndAdministrativeExpenseMember 2021-10-01 2021-12-31
0001527613 us-gaap:GeneralAndAdministrativeExpenseMember 2020-10-01
2020-12-31 0001527613 us-gaap:VehiclesMember
NUZE:FordMotorCreditMember 2019-03-30 2019-04-02 0001527613
us-gaap:VehiclesMember NUZE:FordMotorCreditMember 2019-04-02
0001527613 NUZE:FordMotorCreditMember 2021-12-31 0001527613
NUZE:FordMotorCreditMember 2021-09-30 0001527613
NUZE:NuZeeKoreaLtdMember us-gaap:EquipmentMember
NUZE:ShinHanBankMember 2019-02-15 0001527613
us-gaap:EquipmentMember NUZE:ShinHanBankMember
NUZE:NuZeeKoreaLtdMember 2019-06-27 2019-06-28 0001527613
NUZE:NuZeeKoreaLtdMember us-gaap:EquipmentMember
NUZE:ShinHanBankMember 2019-02-14 2019-02-15 0001527613
NUZE:NuZeeKoreaLtdMember NUZE:ShinHanBankMember 2021-12-31
0001527613 NUZE:NuZeeKoreaLtdMember NUZE:ShinHanBankMember
2021-09-30 0001527613 NUZE:JointVentureAgreementMember
NUZE:IndustrialMarinoSADeCVAndNuZeeLatinAmericaSADeCVMember
2020-01-09 0001527613 NUZE:JointVentureAgreementMember 2020-01-09
0001527613 NUZE:NLAMember 2021-10-01 2021-12-31 0001527613
NUZE:NLAMember NUZE:MachinesMember 2021-10-01 2021-12-31 0001527613
NUZE:NLAMember 2020-10-01 2020-12-31 0001527613
us-gaap:SalesRevenueNetMember NUZE:CustomerWPMember
us-gaap:CustomerConcentrationRiskMember 2021-10-01 2021-12-31
0001527613 us-gaap:AccountsReceivableMember NUZE:CustomerWPMember
us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001527613
us-gaap:AccountsReceivableMember NUZE:CustomerWPMember
us-gaap:CustomerConcentrationRiskMember 2021-10-01 2021-12-31
0001527613 us-gaap:SalesRevenueNetMember NUZE:CustomerCUMember
us-gaap:CustomerConcentrationRiskMember 2021-10-01 2021-12-31
0001527613 us-gaap:AccountsReceivableMember NUZE:CustomerCUMember
us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001527613
us-gaap:AccountsReceivableMember NUZE:CustomerCUMember
us-gaap:CustomerConcentrationRiskMember 2021-10-01 2021-12-31
0001527613 us-gaap:SalesRevenueNetMember NUZE:CustomerWPMember
us-gaap:CustomerConcentrationRiskMember 2020-10-01 2020-12-31
0001527613 us-gaap:AccountsReceivableMember NUZE:CustomerWPMember
us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001527613
us-gaap:AccountsReceivableMember NUZE:CustomerWPMember
us-gaap:CustomerConcentrationRiskMember 2020-10-01 2020-12-31
0001527613 us-gaap:SalesRevenueNetMember NUZE:CustomerRSMMember
us-gaap:CustomerConcentrationRiskMember 2020-10-01 2020-12-31
0001527613 us-gaap:AccountsReceivableMember NUZE:CustomerRSMMember
us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001527613
us-gaap:AccountsReceivableMember NUZE:CustomerRSMMember
us-gaap:CustomerConcentrationRiskMember 2020-10-01 2020-12-31
0001527613 us-gaap:SalesRevenueNetMember NUZE:CustomerGRMember
us-gaap:CustomerConcentrationRiskMember 2020-10-01 2020-12-31
0001527613 us-gaap:AccountsReceivableMember NUZE:CustomerGRMember
us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001527613
us-gaap:AccountsReceivableMember NUZE:CustomerGRMember
us-gaap:CustomerConcentrationRiskMember 2020-10-01 2020-12-31
0001527613 NUZE:ShinHanBankMember 2021-12-31 0001527613
srt:NorthAmericaMember 2021-10-01 2021-12-31 0001527613
srt:NorthAmericaMember 2020-10-01 2020-12-31 0001527613 country:KR
2020-10-01 2020-12-31 0001527613 srt:NorthAmericaMember 2021-12-31
0001527613 srt:NorthAmericaMember 2021-09-30 0001527613 country:KR
2021-12-31 0001527613 country:KR 2021-09-30 0001527613 country:JP
2021-12-31 0001527613 country:JP 2021-09-30 0001527613
NUZE:NuZeeLatinAmericaMember 2021-10-01 2021-12-31 0001527613
NUZE:NuZeeLatinAmericaMember 2020-10-01 2020-12-31 0001527613
NUZE:SeriesAWarrantMember 2021-12-31 0001527613
NUZE:SeriesBWarrantMember 2021-12-31 0001527613
NUZE:EquityDistributionAgreementMember
NUZE:AtTheMarketOfferingMember 2021-12-27 2021-12-28 0001527613
NUZE:EquityDistributionAgreementMember 2021-12-27 2021-12-28
0001527613 NUZE:TerminationOfEmploymentMember 2021-10-01 2021-12-31
0001527613 NUZE:StockOptionsMember 2021-10-01 2021-12-31 0001527613
NUZE:StockOptionsMember 2020-10-01 2020-12-31 0001527613 2020-06-23
0001527613 2020-06-22 2020-06-23 0001527613
NUZE:UnderwritenOverAllotmentOptionMember us-gaap:WarrantMember
2021-03-18 2021-03-19 0001527613 NUZE:SeriesAWarrantMember
2021-03-19 0001527613 NUZE:SeriesBWarrantMember 2021-03-19
0001527613 us-gaap:SubsequentEventMember
NUZE:AtTheMarketOfferingEquityDistributionAgreementMember
2022-01-01 2022-02-04 0001527613 us-gaap:SubsequentEventMember
NUZE:AtTheMarketOfferingEquityDistributionAgreementMember
NUZE:AgentMember 2022-01-01 2022-02-04 0001527613
us-gaap:SubsequentEventMember srt:DirectorMember 2022-01-09
2022-01-11 0001527613 us-gaap:SubsequentEventMember
srt:DirectorMember 2022-01-11 0001527613
us-gaap:SubsequentEventMember NUZE:AuditCommitteeChairMember
srt:DirectorMember 2022-01-09 2022-01-11 0001527613
us-gaap:SubsequentEventMember NUZE:CompensationCommitteeChairMember
srt:DirectorMember 2022-01-09 2022-01-11 0001527613
us-gaap:SubsequentEventMember
NUZE:NominatingAndCorporateGovernanceCommitteeChairMember
srt:DirectorMember 2022-01-09 2022-01-11 0001527613
us-gaap:BridgeLoanMember 2022-02-03 0001527613
us-gaap:ShareBasedCompensationAwardTrancheOneMember
us-gaap:BridgeLoanMember NUZE:LetterOfIntentMember 2022-02-03
0001527613 us-gaap:ShareBasedCompensationAwardTrancheTwoMember
us-gaap:BridgeLoanMember NUZE:LetterOfIntentMember 2022-02-03
0001527613 us-gaap:BridgeLoanMember NUZE:LetterOfIntentMember
2022-02-09 2022-02-11 0001527613 us-gaap:BridgeLoanMember
NUZE:LetterOfIntentMember 2022-03-31 iso4217:USD xbrli:shares
iso4217:USD xbrli:shares xbrli:pure
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 |
For
the quarterly period ended
December 31, 2021
or
☐ |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 |
For the transition period from ________to________
Commission
File No.
001-39338
NUZEE, INC.
(exact
name of registrant as specified in its charter)
Nevada |
|
38-3849791 |
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
Number)
|
1401 Capital Avenue,
Suite B,
Plano,
TX,
75074
(Address
of principal executive offices) (zip code)
(760)
295-2408
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, $0.00001 par value |
|
NUZE |
|
The
NASDAQ Stock Market LLC |
Indicate
by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for
the past 90 days.
Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer or a smaller
reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large
accelerated filer |
☐ |
|
Accelerated
Filer |
☐ |
Non-accelerated filer |
☒ |
|
Smaller
reporting company |
☒ |
Emerging
growth company |
☐ |
|
|
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). Yes ☐
No ☒
As of
February 4, 2022, the registrant had
18,209,697 shares of common stock outstanding.
Table
of Contents
SPECIAL
NOTE REGARDING FORWARD LOOKING STATEMENTS
This
report includes “forward looking statements” within the meaning of
Section 27A of the Securities Act of 1933, as amended (the
“Securities Act”), and Section 21E of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), Such forward-looking
statements reflect the views of NuZee, Inc. (“NuZee” or the
“Company”) with respect to future events and financial performance.
These forward-looking statements are subject to certain
uncertainties and other factors that could cause actual results to
differ materially from such statements. From time to time, our
management or persons acting on our behalf may make forward-looking
statements to inform existing and potential security holders about
the Company. All statements other than statements of historical
facts included in this report regarding our financial position,
business strategy, plans and objectives of management for future
operations, industry conditions, and indebtedness covenant
compliance, or any other matters, are forward-looking statements.
When used in this report, forward-looking statements are generally
accompanied by terms or phrases such as “estimate,” “expects”,
“project,” “predict,” “believe,” “expect,” “anticipate,” “target,”
“plan,” “intend,” “seek,” “goal,” “will,” “should,” “may” or other
words and similar expressions that convey the uncertainty of future
events or outcomes. Items contemplating or making assumptions
about, actual or potential future sales, market size,
collaborations, and trends or operating results also constitute
such forward-looking statements. We undertake no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events, or
otherwise.
Forward-looking
statements in this report may include, without limitation,
statements regarding:
|
● |
our
plans to obtain funding for our operations, including funding
necessary to develop, manufacture and commercialize our products
and provide our co-packing services; |
|
|
|
|
● |
the
impact to our business from the COVID-19 global crisis, including
any supply chain interruptions; |
|
|
|
|
● |
the
evolving coffee preferences of coffee consumers in North America
and Korea; |
|
|
|
|
● |
the
size and growth of the markets for our products and co-packing
services; |
|
|
|
|
● |
our
ability to compete with companies producing similar products or
providing similar co-packing services; |
|
|
|
|
● |
our
expectation that our existing capital resources will be sufficient
to fund our operations for at least the next 12
months; |
|
|
|
|
● |
our
expectation regarding our future co-packing
revenues; |
|
|
|
|
● |
our
ability to develop innovative new products and expand our
co-packing services to other products that are complementary to our
current single serve coffee product offerings; |
|
|
|
|
● |
our
reliance on third-party roasters to roast coffee beans necessary to
manufacture our products and fulfill every aspect of our co-packing
services; |
|
|
|
|
● |
regulatory
developments in the U.S. and in non-U.S. countries; |
|
|
|
|
● |
our
ability to retain key management, sales, and marketing
personnel; |
|
|
|
|
● |
the
scope of protection we are able to establish and maintain for
intellectual property rights covering our products and
technology; |
|
|
|
|
● |
the
accuracy of our estimates regarding expenses, future revenue,
capital requirements and needs for additional
financing; |
|
|
|
|
● |
our
ability to develop and maintain our corporate infrastructure,
including our internal control over financial
reporting; |
|
|
|
|
● |
the
outcome of pending, threatened or future litigation;
and |
|
|
|
|
● |
our
financial performance. |
The
forward-looking statements are not meant to predict or guarantee
actual results, performance, events, or circumstances and may not
be realized because they are based upon our current projections,
plans, objectives, beliefs, expectations, estimates and assumptions
and are subject to a number of risks and uncertainties and other
influences, many of which we have no control over. Actual results
and the timing of certain events and circumstances may differ
materially from those described by the forward-looking statements
as a result of these risks and uncertainties. Forward-looking
statements speak only as of the date they are made. You should
consider carefully the statements in the section of our Annual
Report on Form 10-K filed with the SEC on December 22, 2021, titled
“Risk Factors” and sections of this report that describe factors
that could cause our actual results to differ from those set forth
in the forward-looking statements.
Readers
are urged not to place undue reliance on these forward-looking
statements, which speak only as of the date of this report. We
assume no obligation to update any forward-looking statements in
order to reflect any event or circumstance that may arise after the
date of this report, other than as may be required by applicable
law or regulation. Readers are urged to carefully review and
consider the various disclosures made by us in our reports filed
with the Securities and Exchange Commission which attempt to advise
interested parties of the risks and factors that may affect our
business, financial condition, results of operation and cash flows.
If one or more of these risks or uncertainties materialize, or if
the underlying assumptions prove incorrect, our actual results may
vary materially from those expected or projected.
Item 1. Financial Statements.
NuZee,
Inc.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
The
accompanying notes are an integral part of these unaudited
consolidated financial statements
NuZee,
Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
The
accompanying notes are an integral part of these unaudited
consolidated financial statements
NuZee,
Inc.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(LOSS)
(UNAUDITED)
The
accompanying notes are an integral part of these unaudited
consolidated financial statements
NuZee,
Inc.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’
EQUITY
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
other |
|
|
|
|
|
|
Common stock |
|
|
paid-in |
|
|
Accumulated |
|
|
comprehensive |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
capital |
|
|
deficit |
|
|
income |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance September 30,
2020 |
|
|
14,570,105 |
|
|
$ |
146 |
|
|
$ |
40,472,229 |
|
|
$ |
(34,272,778 |
) |
|
$ |
190,161 |
|
|
$ |
6,389,758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
Equity securities
issued for cash |
|
|
324,959 |
|
|
|
3 |
|
|
|
2,683,977 |
|
|
|
- |
|
|
|
- |
|
|
|
2,683,980 |
|
Stock option expense |
|
|
- |
|
|
|
- |
|
|
|
4,507,298 |
|
|
|
- |
|
|
|
- |
|
|
|
4,507,298 |
|
Exercise of stock options |
|
|
6,000 |
|
|
|
- |
|
|
|
9,180 |
|
|
|
- |
|
|
|
- |
|
|
|
9,180 |
|
Other comprehensive gain |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,656 |
|
|
|
1,656 |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(5,896,072 |
) |
|
|
|
|
|
|
(5,896,072 |
) |
Balance
December 31, 2020 |
|
|
14,901,064 |
|
|
$ |
149 |
|
|
$ |
47,672,684 |
|
|
$ |
(40,168,850 |
) |
|
$ |
191,817 |
|
|
$ |
7,695,800 |
|
The
accompanying notes are an integral part of these unaudited
consolidated financial statements.
NuZee,
Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
The
accompanying notes are an integral part of these unaudited
consolidated financial statements
NuZee,
Inc.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
December
31, 2021
1.
BASIS OF PRESENTATION
AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
The
accompanying unaudited interim consolidated financial statements of
NuZee, Inc. (together with its subsidiaries, referred to herein as
the “Company”, “we” or “NuZee”) have been prepared in accordance
with accounting principles generally accepted in the United States
of America (“GAAP”), and rules of the Securities and Exchange
Commission (the “SEC”), and should be read in conjunction with the
audited consolidated financial statements and notes thereto
contained in the Company’s Annual Report on Form 10-K for the year
ended September 30, 2021 as filed with the SEC on December 22,
2021. In the opinion of management, all adjustments, consisting of
recurring adjustments, necessary for a fair presentation of
financial position and the results of operations for the interim
periods presented have been reflected herein. The results of
operations for interim periods are not necessarily indicative of
the results to be expected for the full year. Notes to the
financial statements which would substantially duplicate the
disclosure contained in the audited financial statements as
reported in the Annual Report on Form 10-K for the year ended
September 30, 2021 have been omitted.
Reclassification
Certain
amounts in the prior period financial statements have been
reclassified to conform to the presentation of the current period
financial statements. These reclassifications had no effect on the
previously reported net loss.
Principles of
Consolidation
The
Company prepares its financial statements on the accrual basis of
accounting. The accompanying consolidated financial statements
include the accounts of the Company and its wholly owned
subsidiaries. All significant intercompany accounts, balances and
transactions have been eliminated upon consolidation.
The
Company has two wholly owned international subsidiaries in NuZee
KOREA Ltd. (“NuZee KR”) and NuZee Investment Co., Ltd. (“NuZee
INV”).
Earnings per
Share
Basic
earnings per common share is equal to net earnings or loss divided
by the weighted average of shares outstanding during the reporting
period. Diluted earnings per share reflects the potential dilution
that could occur if stock options, warrants and other commitments
to issue common stock were exercised or equity awards vest
resulting in the issuance of common stock that could share in the
earnings of the Company. As of December 31, 2021 and December 31,
2020, the total number of common stock equivalents was 8,766,493 and 2,314,053, respectively,
comprised of stock options and warrants as of December 31, 2021 and
December 30, 2020. The Company incurred a net loss for the three
months ended December 31, 2021 and 2020, respectively, and
therefore basic and diluted earnings per share for those periods
are the same because all potential common equivalent shares would
be antidilutive.
Capital
Resources
Since
its inception, the Company has devoted substantially all its
efforts to business planning, research and development, recruiting
management and technical staff, acquiring operating assets, raising
capital, and the commercialization and manufacture of its single
serve coffee products. The Company has generated limited revenues
from its principal operations, and there is no assurance of future
revenues.
As of
December 31, 2021, the Company had cash of $10,967,104. However, the Company has not
attained profitable operations since inception.
Major
Customers
In
the three months ended December 31, 2021 and 2020, revenue was
primarily derived from major customers disclosed below.
Three
months ended December 31, 2021:
SCHEDULE OF REVENUE BY MAJOR
CUSTOMERS
Customer Name |
|
Sales Amount |
|
|
% of Total Revenue |
|
|
Accounts
Receivable
Amount
|
|
|
% of Total Accounts Receivable |
|
Customer WP |
|
$ |
310,551 |
|
|
|
30 |
% |
|
$ |
279,273 |
|
|
|
35 |
% |
Customer CU |
|
$ |
199,936 |
|
|
|
20 |
% |
|
$ |
137,566 |
|
|
|
17 |
% |
Three
months ended December 31, 2020:
Customer Name |
|
Sales Amount |
|
|
% of Total Revenue |
|
|
Accounts
Receivable
Amount
|
|
|
% of Total Accounts Receivable |
|
Customer WP |
|
$ |
156,299 |
|
|
|
30 |
% |
|
$ |
94,066 |
|
|
|
43 |
% |
Customer RSM |
|
$ |
66,811 |
|
|
|
13 |
% |
|
$ |
- |
|
|
|
0 |
% |
Customer GR |
|
$ |
65,536 |
|
|
|
13 |
% |
|
$ |
65,352 |
|
|
|
30 |
% |
Lease
In
February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842),
to provide guidance on recognizing lease assets and lease
liabilities on the consolidated balance sheet and disclosing key
information about leasing arrangements, specifically
differentiating between different types of leases. The Company
implemented ASU No. 2016-02 on October 1, 2019.
The
Company performs a quarterly analysis of leases to determine if
there are any operating leases that require recognition under ASC
842. The Company has one significant long-term operating lease for
office and manufacturing space in Plano, Texas. The leased property
in Plano, Texas, has a remaining lease term through June 2024. The
lease has an option to extend beyond the stated termination date,
but exercise of this option is not probable. The Company did not
apply the recognition requirements of ASC 842 to operating leases
with a remaining lease term of 12 months or less.
During
our analysis of leases in the three months ended December 31, 2021,
we determined to renew the office and manufacturing space in Vista,
California which was originally scheduled to expire on January 31, 2022, for an
additional year through January 31, 2023. The lease has a monthly
lease expense of $8,451, plus common area
expenses. We extended our
sub-leased property in Vista, California, through January 31, 2023,
which has been calculated as a ROU Asset co-terminus with the
direct-leased property. The Seoul, Korea office and manufacturing
space lease was extended through June 2022 and there is an
apartment leased through June 2022. Additionally, the Company
leased a new larger office and manufacturing space in Seoul, Korea
beginning November 15, 2021, through November 15, 2023. The
lease has a monthly expense of $7,040. Accordingly, we have
added ROU assets and lease liabilities related to those leases at
December 31, 2021.
As of
December 31, 2021, our operating leases had a weighted average
remaining lease term of 1.7
years and a weighted-average discount rate of 5%.
Other information related to our operating leases is as
follows:
SCHEDULE OF OTHER INFORMATION RELATED TO
OPERATING LEASE
|
|
|
1 |
|
ROU Asset – October 1, 2021 |
|
$ |
386,587 |
|
ROU Asset added during the period |
|
|
192,397 |
|
Amortization
during the period |
|
|
(36,822 |
) |
ROU Asset
–December 31, 2021 |
|
$ |
542,162 |
|
Lease Liability – October 1, 2021 |
|
$ |
398,587 |
|
Lease Liability added during the
period |
|
|
192,397 |
|
Amortization
during the period |
|
|
(36,949 |
) |
Lease Liability – December 31,
2021 |
|
$ |
554,035 |
|
Lease Liability –
Short-Term |
|
$ |
205,098 |
|
Lease Liability
– Long-Term |
|
|
348,937 |
|
Lease Liability
– Total |
|
$ |
554,035 |
|
The
table below reconciles the fixed component of the undiscounted cash
flows for each of the first five years and the total remaining
years to the lease liabilities recorded on the Consolidated Balance
Sheet as of December 31, 2021:
Amounts
due within 12 months of December 31,
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS
FOR OPERATING LEASES
|
|
|
2021 |
|
2022 |
|
$ |
335,586 |
|
2023 |
|
|
220,913 |
|
2024 |
|
|
64,936 |
|
2025 |
|
|
- |
|
2026 |
|
|
- |
|
Total Minimum Lease Payments |
|
|
621,435 |
|
Less Effect of
Discounting |
|
|
(67,400 |
) |
Present Value of Future Minimum Lease
Payments |
|
|
554,035 |
|
Less Current
Portion of Operating Lease Obligations |
|
|
205,098 |
|
Long-Term
Operating Lease Obligations |
|
$ |
348,937 |
|
On
October 9, 2019, the Company entered into a lease agreement with
Alliance Funding Group which provided for a sale lease back on
certain packing equipment. The terms of this agreement require us
to pay $2,987
per
month through July 2024. As part of this agreement, Alliance
Funding Group provided our equipment supplier with $124,500
for
the purchase of this equipment. This transaction was accounted for
as a financing lease. As of December 31, 2021, our financing lease
had a remaining lease term of
2.5 years
and a discount rate of
12.75%.
The interest expense on finance lease liabilities for the three
months ended December 31, 2021 was $2,437.
During
the year ended September 30, 2021, we recorded an impairment to
fully write off the related equipment as it was deemed no longer
useful for our operations.
The
table below summarizes future minimum finance lease payments at
December 31, 2021 for the 12 months ended December 31:
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR
FINANCE LEASES
|
|
|
2021 |
|
2022 |
|
$ |
33,113 |
|
2023 |
|
|
33,113 |
|
2024 |
|
|
19,316 |
|
2025 |
|
|
- |
|
2026 |
|
|
- |
|
Total Minimum Lease Payments |
|
|
85,542 |
|
Amount
representing interest |
|
|
(12,983 |
) |
Present Value of Minimum Lease
Payments |
|
|
72,559 |
|
Current Portion
of Finance Lease Obligations |
|
|
28,729 |
|
Finance Lease
Obligations, Less Current Portion |
|
$ |
43,830 |
|
Rent
expense included in general and administrative expense for the
three months ended December 31, 2021 and 2020 was $90,525
and $93,750,
respectively.
Cash
and non-cash activities associated with the leases for the three
months ended December 31, 2021 are as follows:
SCHEDULE OF CASH AND NON-CASH ACTIVITIES OF
LEASES
Operating cash outflows
from operating leases: |
|
$ |
36,949 |
|
Operating cash outflows from finance
lease: |
|
$ |
2,437 |
|
Financing cash outflows from finance
lease: |
|
$ |
5,841 |
|
In
September 2020, we subleased the space at 1700 Capital Avenue in
Plano, Texas, effective October 1, 2020, under favorable terms that
are co-terminus with the original lease ending June 30, 2024.
During the three months ended December 31, 2021, we recognized
sublease income of $42,757 pursuant to the sublease
included in Other income on our financial statements. Future
minimum lease payments to be received under that sublease as of
December 31, 2021, for each of the twelve months ended December 31
are as follows:
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS OF
SUBLEASE
|
|
|
2021 |
|
2022 |
|
$ |
124,190
|
|
2023 |
|
|
127,926
|
|
2024 |
|
|
64,918
|
|
2025 |
|
|
- |
|
2026 |
|
|
- |
|
Total |
|
$ |
317,034 |
|
Loans
On
April 1, 2019, we purchased a delivery van from Ford Motor Credit
for $41,627.
The Company paid $3,500
as a
down payment and financed $38,127
for
60 months
at a rate of
2.9%.
The loan is secured by the van. The outstanding balance on the loan
at December 31, 2021 and September 30, 2021 amounted to $18,506
and
$20,416,
respectively.
On
February 15, 2019, NuZee KR entered into equipment financing for
production equipment with Shin Han Bank for $60,563.
In June 2019, NuZee KR purchased additional equipment and increased
the loan with Shin Han Bank by $86,518.
The financing has a term of
36 months
at a rate of
4.33%.
Principal payments began in July 2019. The outstanding balance on
this loan at December 31, 2021 and September 30, 2021 amounted to
$23,833
and
$35,898,
respectively.
The
remaining loan payments are as follows:
SCHEDULE OF LOAN PAYMENTS
|
|
Ford Motor
Credit |
|
|
ShinHan
Bank |
|
|
Total |
|
2022 (Jan 2022 - Sep
2022) |
|
$ |
5,812 |
|
|
$ |
13,248 |
|
|
$ |
19,060 |
|
2023 (Oct 2022
- Dec 2022) |
|
|
1,965 |
|
|
|
10,585 |
|
|
|
12,550 |
|
Total Current
Portion |
|
$ |
7,777 |
|
|
$ |
23,833 |
|
|
$ |
31,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 (Jan 2023 - Sep 2023) |
|
$ |
8,005 |
|
|
|
- |
|
|
$ |
8,005 |
|
2024 |
|
|
2,724 |
|
|
|
- |
|
|
|
2,724 |
|
Total Long-Term
Portion |
|
$ |
10,729 |
|
|
$ |
- |
|
|
$ |
10,729 |
|
Grand
Total |
|
$ |
18,506 |
|
|
$ |
23,833 |
|
|
$ |
42,339 |
|
Revenue
Recognition
In
May 2014, the FASB issued Accounting Standards Update No. 2014-09
(Topic 606) “Revenue from Contracts with Customers.” Topic 606
supersedes the revenue recognition requirements in Topic 605
“Revenue Recognition” (Topic 605). The new standard’s core
principle is that an entity will recognize revenue at an amount
that reflects the consideration to which the entity expects to be
entitled in exchange for transferring goods or services to a
customer. The principles in the standard are applied in five steps:
1) Identify the contract(s) with a customer; 2) Identify the
performance obligations in the contract; 3) Determine the
transaction price; 4) Allocate the transaction price to the
performance obligations in the contract; and 5) Recognize revenue
when (or as) the entity satisfies a performance obligation. We
adopted Topic 606 as of October 1, 2018, on a modified
retrospective basis. The adoption of Topic 606 did not have a
material impact on our consolidated financial statements, including
the presentation of revenues in our Consolidated Statements of
Operations.
Foreign Currency
Translation
The
financial position and results of operations of each of the
Company’s foreign subsidiaries are measured using the foreign
subsidiary’s local currency as the functional currency. Revenues
and expenses of each such subsidiary have been translated into U.S.
dollars at average exchange rates prevailing during the period.
Assets and liabilities have been translated at the rates of
exchange on the balance sheet date. The resulting translation gain
and loss adjustments are recorded directly as a separate component
of stockholders’ equity unless there is a sale or complete
liquidation of the underlying foreign investment. Foreign currency
translation adjustments recorded to other comprehensive gain
amounted to $32,688 and
$1,656 for
the three months ended December 31, 2021 and 2020,
respectively.
Transaction
gains and losses that arise from exchange rate fluctuations on
transactions denominated in a currency other than the functional
currency are included in the results of operations as
incurred.
Inventories
Inventory,
consisting principally of raw materials, work in process and
finished goods held for production and sale, is stated at the lower
of cost or net realizable value, cost being determined using the
weighted average cost method. The Company reviews inventory levels
at least quarterly and records a valuation allowance when
appropriate. At December 31, 2021 and September 30, 2021, the
carrying value of inventory was $384,198 and $573,464, respectively.
SCHEDULE OF INVENTORY
|
|
December 31, 2021 |
|
|
September 30, 2021 |
|
Raw materials |
|
$ |
366,639 |
|
|
$ |
552,621 |
|
Finished
goods |
|
|
17,559 |
|
|
|
20,843 |
|
Less –
Inventory reserve |
|
|
- |
|
|
|
- |
|
Total |
|
$ |
384,198 |
|
|
$ |
573,464 |
|
Joint
Venture
On
January 9, 2020, a joint venture agreement was signed between
Industrial Marino, S.A. de C.V. (50%) and the Company (50%)
forming NuZee LATIN AMERICA (NLA), S.A. de C.V. NLA was formed
pursuant to the laws of Mexico, with corporate domicile in
Mazatlan, Mexico. As part of the capitalization of NLA, the Company
contributed two co-packing machines to the joint venture. These
machines had an aggregate carrying cost of $313,012. The Company received
$110,000 in cash for this
contribution and recorded an investment in NLA of $160,000 and a loss of $43,012 on the contribution of
the machines to NLA.
The
Company accounts for NLA using the equity method of accounting
since the management of day-to-day operations at NLA ultimately
lies with the Company’s joint venture partner as the operations of
NLA are based in its partners facilities and our partner appoints
the Chairman of the joint board of directors of NLA. As of December
31, 2021, the only activity in NLA was the contribution of two
machines as described above and other start up related activities.
$1,157
of a loss and $2,056 of a loss was recognized
under the equity method of accounting during the three months ended
December 31, 2021, and December 31, 2020 respectively.
2.
GEOGRAPHIC
CONCENTRATION
The
Company is organized based on fundamentally one business segment
although it does sell its products on a world-wide basis. The
Company is organized in three geographical segments. The Company
co-packs product for customers and produces and sells its products
directly in North America and Korea. The Company has a minimally
staffed office in Japan that provides support for import and export
of product and materials between the U.S. and Japan, as well as
investor relations support to our shareholders based in Japan.
Information about the Company’s geographic operations for the three
months ended December 31, 2021 and 2020 are as follows:
Geographic
Concentrations
SCHEDULE OF GEOGRAPHIC
OPERATIONS
|
|
Three Months
Ended |
|
|
Three Months
Ended |
|
|
|
December 31,
2021 |
|
|
December 30,
2020 |
|
Net
Revenue: |
|
|
|
|
|
|
|
|
North America |
|
$ |
817,341 |
|
|
$ |
406,488 |
|
South
Korea |
|
|
201,912 |
|
|
|
111,499 |
|
Net
Revenue |
|
$ |
1,019,253 |
|
|
$ |
517,987 |
|
Property and equipment, net: |
|
As
of
December 31, 2021 |
|
|
As
of
September 30, 2021 |
|
North America |
|
$ |
462,389 |
|
|
$ |
517,966 |
|
South Korea |
|
|
176,810 |
|
|
|
154,562 |
|
Japan |
|
|
1,123 |
|
|
|
1,496 |
|
Property
and equipment, net |
|
$ |
640,322 |
|
|
$ |
674,024 |
|
3.
RELATED PARTY
TRANSACTIONS
For
the three months ended December 31, 2021 and December 31, 2020,
respectively, the Company had sales of $0 and $15,998 of materials to
NLA.
4.
ISSUANCE OF EQUITY
SECURITIES
Exercise of Warrants
In the three months ended December 31, 2021, we issued 384,447 shares of
common stock related to exercises of warrants, including
380,447 shares of common stock issued upon exercise of
380,447 Series A Warrants and
4,000 shares of common stock issued upon exercise of
8,000 Series B Warrants. In connection with such exercises,
in the three months ended December 31, 2021, we received aggregate
net proceeds of $1,721,018.
ATM
Offering
On
December 28, 2021, we entered into an Equity Distribution Agreement
(the “Equity Distribution Agreement”) with Maxim Group LLC, as
agent (the “Agent”), pursuant to which we may offer and sell, from
time to time, shares of our common stock through the Agent in
“at-the-market-offerings”, as defined in Rule 415 under the
Securities Act, having an aggregate offering price of up to
$20,000,000, subject to any
applicable limits when using Form S-3 (the “ATM Offering”).
Pursuant to the Equity Distribution Agreement, we will pay the
Agent a commission rate, in cash, equal to 3.0% of the
aggregate gross proceeds from each sale of shares of our common
stock under the Equity Distribution Agreement. The offer and sale
of shares of our common stock will be made pursuant to a shelf
registration statement on Form S-3 and the related prospectus (File
No. 333-248531) initially filed by us with the SEC on September 1,
2020, and declared effective by the SEC on October 2, 2020, under
the Securities Act. We are not obligated to make any sales of
shares of our common stock under the Equity Distribution Agreement.
As of December 31, 2021, no sales had occurred under the Equity
Distribution Agreement. For information regarding sales made under
the Equity Distribution Agreement following the quarter ended
December 31, 2021, see Note 6—Subsequent Events.
5.
STOCK OPTIONS AND
WARRANTS
Options
During
the three months ended December 31, 2021, the Company granted no
new stock options, had 192,666 of
stock options that were forfeited because of the termination of
employment, and issued no shares upon the exercise of outstanding
stock options.
The
following table summarizes stock option activity for three months
ended December 31, 2021:
SUMMARY OF STOCK OPTION
ACTIVITY
|
|
Number of Shares |
|
|
Weighted Average
Exercise Price |
|
|
Weighted Average Remaining Contractual Life (years) |
|
|
Aggregate Intrinsic Value |
|
Outstanding at September 30, 2021 |
|
|
4,511,691 |
|
|
$ |
4.73 |
|
|
|
8.4 |
|
|
$ |
452,206 |
|
Granted |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Expired |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(192,666 |
) |
|
|
14.11 |
|
|
|
|
|
|
|
|
|
Outstanding at December 31,
2021 |
|
|
4,319,025 |
|
|
$ |
4.31 |
|
|
|
8.2 |
|
|
$ |
4,320,497 |
|
Exercisable at December 31,
2021 |
|
|
1,704,638 |
|
|
$ |
4.82 |
|
|
|
7.1 |
|
|
$ |
1,953,581 |
|
The
Company is expensing these stock option awards on a straight-line
basis over the requisite service period. The Company recognized
stock option expense of $1,124,187
for
the three months ended December 31, 2021. Unamortized option
expense as of December 31, 2021 for all options outstanding
amounted to $3,603,243.
These costs are expected to be recognized over a weighted average
period of
1.3 years.
The Company recognized stock option expense of $4,507,298
for
the three months ended December 31, 2020.
A
summary of the status of the Company’s nonvested options as of
December 31, 2021 is presented below:
SUMMARY OF UNVESTED SHARES
Nonvested options
|
|
Number of
Nonvested Options |
|
|
Weighted Average
Grant Date Fair Value |
|
Nonvested options at
September 30, 2021 |
|
|
2,870,799 |
|
|
$ |
5.02 |
|
Granted |
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
(26,000 |
) |
|
|
2.60 |
|
Vested |
|
|
(230,412 |
) |
|
|
6.09 |
|
Nonvested
options at December 31, 2021 |
|
|
2,614,387 |
|
|
$ |
4.95 |
|
Warrants
On
June 23, 2020, as part of our agreement with Benchmark Company,
LLC, the underwriter of the Company’s June 2020 registered public
offering of common stock, we issued 40,250 warrants to
purchase our common stock at an exercise price of $9.00 a share. These warrants
are exercisable on December 23, 2020 and
expire on June 18, 2025.
On
March 19, 2021, we entered into an underwriting agreement in
connection with our registered public offering (the “Offering”) of
(i) 2,777,777 units (the
“Units”), at a price to the public of $4.50 per Unit, with each Unit
consisting of (a) one share of our common stock, (b) one Series A
Warrant, and (c) one Series B Warrant (together with the Series A
Warrants, the “Warrants”), and (ii) 416,666 Series A Warrants and
416,666 Series B Warrants, each pursuant to the underwriter’s full
exercise of their overallotment option with respect to such
warrants.
Each
Series A Warrant entitles the registered holder to purchase one
share of our common stock at an exercise price of $4.50 per share. Each Series B
Warrant entitles the registered holder thereof to purchase one-half
of a share of our common stock at an exercise price of $5.85 per whole share. These
warrants have a term of 5 years.
The
Series A and Series B Warrant holders are obligated to pay the
exercise price in cash upon exercise of the Warrants unless we fail
to maintain a current prospectus relating to the common stock
issuable upon the exercise of the Warrants (in which case, the
Warrants may only be exercised via a “cashless” exercise
provision).
The
following table summarizes warrant activity for the three months
ended December 31, 2021:
SCHEDULE OF WARRANT
ACTIVITY
|
|
Number of Shares Issuable Upon Exercise of Warrants |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contractual Life (years) |
|
|
Aggregate
Intrinsic Value |
|
Outstanding at September 30, 2021 |
|
|
4,831,915 |
|
|
$ |
4.98 |
|
|
|
4.5 |
|
|
$ |
- |
|
Issued |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(384,447 |
) |
|
|
4.51 |
|
|
|
|
|
|
|
|
|
Expired |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Outstanding at December 31,
2021 |
|
|
4,447,468 |
|
|
$ |
5.02 |
|
|
|
4.2 |
|
|
|
- |
|
Exercisable at December 31,
2021 |
|
|
4,447,468 |
|
|
$ |
5.02 |
|
|
|
4.2 |
|
|
$ |
- |
|
In the three months ended December 31, 2021, we issued
384,447 shares of common stock related to exercises of
warrants, including
380,447 shares of common stock issued upon exercise of
380,447 Series A Warrants and
4,000 shares of common stock issued upon exercise of
8,000 Series B Warrants. In connection with such exercises,
in the three months ended December 31, 2021, we received aggregate
net proceeds of $1,721,018.
6.
SUBSEQUENT
EVENTS
ATM Offering—Sales under Equity Distribution
Agreement
During the period from January 1, 2022 through February 4, 2022, we
issued and sold 4,860 shares of our
common stock under the Equity Distribution Agreement, raising net
proceeds of $12,542. In
connection with such sales, we paid compensation to the Agent in
the amount of $388. See Note 4—Issuance of
Equity Securities for additional information related to the Equity
Distribution Agreement and the ATM Offering.
Agreement with Farmer
Bros. Co.
As
previously disclosed in 2020, we entered into an Equipment Bailment
and Contract Manufacturing Agreement (the “FBC Agreement”) with
Farmer Bros. Co. (“FBC”), pursuant to which FBC agreed to provide
us with access to manufacturing capacity and was obligated to
manufacture finished products for us. On January 27, 2022, we and
FBC mutually agreed to terminate the FBC Agreement, effective
immediately. Prior to its termination, the Company had placed one
machine with FBC under the FBC Agreement. The Company plans
to pick up the machine within 60 days of the termination date and
redeploy the machine to one of its two manufacturing locations in
the United States.
Director Compensation Policy
On January 11, 2022, the Company’s Board of Directors (the “Board”)
adopted and approved a new director compensation policy pursuant to
which the Company will provide the following compensation to its
non-employee Board members: (i) annual cash compensation of
$50,000,
effective as of October 1, 2021 and payable quarterly in advance;
(ii) payment to each Board member of reasonable out-of-pocket
expenses for travel costs to attend Board meetings; (iii) beginning
with the Company’s 2022 Annual Meeting of Stockholders, pursuant to
the NuZee, Inc. 2019 Stock Incentive Plan, annual grants of
restricted shares of common stock with an aggregate grant date fair
value of $50,000 to each Board
member upon such Board member’s election or re-election, as
applicable, to the Board at each annual meeting of stockholders,
and (iv) annual payments to the Audit Committee Chair, Compensation
Committee Chair and Nominating and Corporate Governance Committee
Chair of $10,000, $7,500 and $5,000,
respectively.
Amended Non-Binding Letter of Intent for Potential Asset
Acquisition; Bridge Loan
As previously disclosed in the Company’s Current Report on Form 8-K
filed on December 29, 2021, the Company announced it entered into a
non-binding letter of intent (the “Letter of Intent”) affording the
Company an exclusivity period lasting until January 31, 2022, to
negotiate a definitive agreement (the “Definitive Agreement”) to
acquire substantially all the assets (the “Potential Transaction”)
of an unaffiliated, privately held company in the coffee industry
(the “Third Party”). On February 3, 2022, the Company and the Third
Party amended the Letter of Intent to extend the exclusivity period
to March 1, 2022 (the “Extension”). In consideration of the
Extension, the Company agreed to loan the Third Party up to
$35,000 in the aggregate in two tranches,
as follows: (i) $13,000 was loaned to the Third Party
on February 3, 2022 and is intended to provide the Third Party with
operational financing while the parties continue negotiations to
enter into a Definitive Agreement; and (ii) $22,000 is expected to be loaned to
the Third Party, if at all, in the event that a Definitive
Agreement is entered into between the parties, which is expected to
be an advance on the purchase price set forth in the Definitive
Agreement and is intended to provide the Third Party with
operational financing as the parties work to close the Potential
Transaction following signing of the Definitive Agreement.
Upon closing of the Potential Transaction
(if any), the first tranche of $13,000 is expected to be designated
as an assumed liability under the Definitive Agreement for the
benefit of the Third Party and the second tranche of $22,000 is
expected to be offset and reduce the purchase price to be paid by
the Company. Except in certain limited circumstances, the
amounts loaned are expected to become due and payable on the later
of the closing of the Potential Transaction (if any) and March 31,
2022. The amounts loaned will accrue interest at the rate of
1% per annum, subject to
increase upon certain events of default.
Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.
Overview
We
are a specialty coffee company and, we believe, a leading co-packer
of single serve pour over coffee in the United States, as well as a
preeminent co-packer of tea-bag style coffee. Our mission is to
leverage our position as a co-packer at the forefront of the North
American single serve coffee market to revolutionize the way single
serve coffee is enjoyed in the United States. While the United
States is our core market, we also have manufacturing and sales
operations in Korea and a joint venture in Latin
America.
We
believe we are the only commercial-scale producer that has the dual
capacity to pack both single serve pour over coffee and tea-bag
style coffee within the North American market. We intend to
leverage our position to be the commercial manufacturer of choice
for major companies seeking to enter the single serve pour over and
tea-bag style coffee markets in North America. We target existing
high-margin companies and are paid per-package based on the number
of single serve coffee products produced by us. Accordingly, we
consider our business model to be a form of tolling arrangement, as
we receive a fee for almost every single serve coffee product our
co-packing customers sell in the North American and Korean markets.
While we financially benefit from the success of our co-packing
customers through the sales of their respective single serve pour
over and tea-bag style coffee products, we are also able to avoid
the risks associated with owning and managing the product and its
related inventory.
We
have also developed and sell NuZee branded single serve coffee
products, including our flagship Coffee Blenders line of both
single serve pour over coffee and tea-bag style coffee, which we
believe offers consumers some of the best coffee available in a
single serve application in the world.
We
may also consider co-packaging other products that are
complementary to our current product offerings and provide us with
a deeper access to our customers. In addition, we are continually
exploring potential strategic partnerships, co-ventures, and
mergers, acquisitions, or other transactions with existing and
future business partners to generate additional business, reduce
manufacturing costs, expand into new markets, and further penetrate
the markets in which we currently operate.
Since
2016, we have been primarily focused on single serve pour over
coffee production. Over this time, we have developed expertise in
the operation of our sophisticated packing equipment and the
related production of our single serve pour over coffee products at
both our Vista, California facility and at our production
operations in Seoul, Korea. In addition, our manufacturing facility
and corporate headquarters in Plano, Texas is now operational. We
have also expanded our co-packing expertise to tea bag style coffee
products, which we believe are gaining traction in the United
States.
Impact of the COVID-19 Pandemic
The
ongoing COVID-19 global and national health emergency has caused
significant disruption in the international and United States
economies and financial markets. In the three months ended December
31, 2021, as a result of the COVID-19 pandemic and responses to the
outbreak, certain of our customers slowed or delayed purchases of
our co-packing services or single serve coffee products, and we
also believe that potential sales of our single serve coffee
products to new or potential customers in the hospitality industry
were adversely impacted. We have also experienced delays in the
submission and approval of custom artwork and packaging as well as
the shipment to us of coffee for co-packing. In addition, we
incurred lost production time due to employee absences. We do not
believe, however, that these delays and disruptions had a
significant effect on our business or results of operations to
date, and in some cases, we have been able to mitigate these
adverse effects in part by sourcing coffee and other supplies from
alternative suppliers in the United States. The COVID-19 crisis may
have an adverse impact on our business and financial results going
forward that we are not currently able to fully determine or
quantify. The COVID-19 crisis may adversely affect the ability of
our customers to pay for goods delivered on a timely basis, or at
all. Any increase in the amount or deterioration in the
collectability of accounts receivable will adversely affect our
cash flows and results of operations, requiring an increased level
of working capital.
Geographic Concentration
Our
operations are primarily split between two geographic areas: North
America and Asia.
For
the three months ended December 31, 2021, net revenues attributable
to our operations in North America totaled $817,341 compared to
$406,488 of net revenues attributable to our operations in North
America for the three months ended December 31, 2020. Additionally,
as of December 31, 2021, $462,389 of our property and equipment,
net was attributable to our North American operations, compared to
$517,966 attributable to our North American operations as of
September 30, 2021.
For
the three months ended December 31, 2021, net revenues attributable
to our operations in Asia totaled $201,912 compared to $111,499 of
net revenues attributable to our operations in Asia during the
three months ended December 31, 2020. Additionally, as of December
31, 2021, $177,933 of our property and equipment, net was
attributable to our Asian operations, compared to $156,058
attributable to our Asian operations as of September 30,
2021.
Results of Operations
Comparison
of three months ended December 31, 2021 and 2020:
Revenue
|
|
Three months
ended
December 31, |
|
|
Change |
|
|
|
2021 |
|
|
2020 |
|
|
Dollars |
|
|
% |
|
Revenue |
|
$ |
1,019,253 |
|
|
$ |
517,987 |
|
|
$ |
501,266 |
|
|
|
97 |
% |
For
the three months ended December 31, 2021, our revenue increased by
$501,266, or approximately 97%, compared with the three months
ended December 31, 2020. This increase was primarily related to
increased co-packing revenue to existing and new customers.
In the third and fourth quarters of fiscal year 2021, we expanded
our U.S. sales and support operations, which resulted in increased
orders and increased co-packing opportunities in the three months
ended December 31, 2021.
Cost
of sales and gross margin
|
|
Three months ended |
|
|
|
|
|
|
December
31, |
|
|
Change |
|
|
|
2021 |
|
|
2020 |
|
|
Dollars |
|
|
% |
|
Cost of sales |
|
$ |
1,003,882 |
|
|
$ |
516,284 |
|
|
$ |
487,598 |
|
|
|
94 |
% |
Gross profit |
|
|
15,371 |
|
|
$ |
1,703 |
|
|
$ |
13,668 |
|
|
|
803 |
% |
Gross profit % |
|
|
2 |
% |
|
|
0 |
% |
|
|
|
|
|
|
|
|
For
the three months ended December 31, 2021, we generated a total
gross profit of $15,371, from sales of our products and co-packing
services, compared to a total gross profit of $1,703 for the three
months ended December 31, 2020. The gross margin rate was 2% for
the three months ended December 31, 2021, and 0% for the three
months ended December 30, 2020. This increase in gross profit was
driven primarily by greater scale in our manufacturing operations
due to increased production during the current quarter versus the
same period in the prior year, combined with increased sales offset
by increased materials and labor costs.
Operating
Expenses
|
|
Three months ended |
|
|
|
|
|
|
|
|
|
December
31, |
|
|
Change |
|
|
|
2021 |
|
|
2020 |
|
|
Dollars |
|
|
% |
|
Operating Expenses |
|
$ |
2,852,793 |
|
|
$ |
5,903,826 |
|
|
$ |
(3,051,033 |
) |
|
|
(52 |
)% |
For
the three months ended December 31, 2021, the Company’s operating
expenses totaled $2,852,793 compared to $5,903,826 for the three
months ended December 31, 2020, representing a 52% decrease. This
decrease is primarily attributable to a decrease in stock-based
compensation expense, offset by an increase in operating expenses
associated with greater staffing levels and marketing
activities.
Net
Loss
|
|
Three months ended |
|
|
|
|
|
|
December
31, |
|
|
Change |
|
|
|
2021 |
|
|
2020 |
|
|
Dollars |
|
|
% |
|
Net Loss |
|
$ |
2,804,203 |
|
|
$ |
5,896,072 |
|
|
$ |
(3,091,869 |
) |
|
|
(52 |
)% |
For
the three months ended December 31, 2021, we generated a net loss
of $2,804,203 versus $5,896,072 for the three months ended December
31, 2020. This decrease in net loss is primarily attributable to
increased revenues and lower stock compensation expense, offset by
an increase in operating expenses associated with greater staffing
levels and marketing activities.
Liquidity and Capital Resources
Since
our inception in 2011, we have incurred significant losses, and as
of December 31, 2021, we had an accumulated deficit of
approximately $55.6 million. We have not yet achieved profitability
and anticipate that we will continue to incur significant sales and
marketing expenses prior to recording sufficient revenue from our
operations to offset these expenses. In the United States, we
expect to incur additional losses because of the costs associated
with operating as an exchange-listed public company. We are unable
to predict the extent of any future losses or when we will become
profitable, if at all.
To
date, we have funded our operations primarily with proceeds from
registered public offerings and private placements of shares of our
common stock. Our principal use of cash is to fund our operations,
which includes the commercialization of our single serve coffee
products, the continuation of efforts to improve our products,
administrative support of our operations and other working capital
requirements.
As of
December 31, 2021, we had a cash balance of $10,967,104. We believe
that our cash and cash equivalents will be sufficient to fund our
planned operations and capital expenditure requirements for at
least 12 months from February 4, 2022. This evaluation is based on
relevant conditions and events that are currently known or
reasonably knowable. As a result, we could deplete our available
capital resources sooner than we currently expect, and a reduction
in consumer demand for, or revenues from the sale of, our single
serve coffee products could further constrain our cash resources.
We have based these estimates on assumptions that may prove to be
wrong, and our operating projections, including our projected
revenues from sales of our single serve coffee products, may change
as a result of many factors currently unknown to us.
On
December 28, 2021, we entered into an Equity Distribution Agreement
(the “Equity Distribution Agreement”) with Maxim Group LLC
(“Maxim”), as agent (the “Agent”), pursuant to which we may offer
and sell, from time to time, shares of our common stock through the
Agent in “at-the-market-offerings”, as defined in Rule 415 under
the Securities Act, having an aggregate offering price of up to
$20,000,000, subject to any applicable limits when using Form S-3
(the “ATM Offering”). During
the period from January 1, 2022 through February 4, 2022, we issued
and sold 4,860 shares of our common stock under the Equity
Distribution Agreement, raising net proceeds of
$12,542.
In
the future, we may seek to raise additional capital through sales
of our common stock under the Equity Distribution Agreement. We
also expect to receive additional funds upon the exercise for cash
of outstanding warrants, if and when exercised at the election of
the warrant holders, including the Series A warrants (the “Series A
Warrants”) and Series B warrants (the “Series B Warrants” and,
collectively with the Series A Warrants, the “Warrants”) that were
sold by us in March 2021 in an underwritten registered public
offering. For additional information regarding the Warrants,
including net proceeds received upon exercise of Warrants in the
quarter ended December 31, 2021, see “—Summary of Cash
Flows—Financing Activities” and Note 5—Stock Options and
Warrants to the Unaudited Consolidated Financial
Statements.
In
the long-term, we may need to raise additional funds to support our
operating activities, and such funding may not be available to us
on acceptable terms, or at all. Our need to raise funds will depend
on a number of factors, including our ability to generate a
sufficient amount of revenues from the sale of our single serve
coffee products to fund our business operations, the timing and
amount of proceeds from sales of our common stock under the Equity
Distribution Agreement, and the timing and amount of funds received
upon the exercise for cash of outstanding warrants by the warrant
holders. If we are unable to raise additional funds when needed,
our operations and ability to execute our business strategy could
be adversely affected. Until we can generate a sufficient amount of
revenue, we may seek to raise additional funds through equity,
equity-linked or debt financings. If we raise additional funds
through the incurrence of indebtedness, such indebtedness would
have rights that are senior to holders of our equity securities and
could contain covenants that restrict our operations. Any
additional equity financing may be dilutive to our
stockholders.
Our
significant contractual cash requirements as of December 31, 2021
primarily include payments for operating and finance lease
liabilities and principal and interest on loans. Additionally, we
may incur purchase obligations in the ordinary course of business
that are enforceable and legally binding and enter into enforceable
agreements to purchase goods or services that specify all
significant terms, including fixed or minimum quantities to be
purchased and fixed or estimated prices to be paid at the time of
settlement. As of December 31, 2021, we had payments for lease and
loan obligations of approximately $668,933, of which $265,437 are
payable within 12 months as of December 31, 2021. We had no
purchase obligations as of December 31, 2021.
Summary
of Cash Flows
|
|
Three Months
Ended |
|
|
|
December
31, |
|
|
|
2021 |
|
|
2020 |
|
Cash used in operating
activities |
|
$ |
(1,579,731 |
) |
|
$ |
(1,699,073 |
) |
Cash used in investing activities |
|
$ |
(3,009 |
) |
|
$ |
(58,990 |
) |
Cash provided by financing
activities |
|
$ |
1,701,202 |
|
|
$ |
2,679,420 |
|
Effect of foreign exchange on
cash |
|
$ |
32,688 |
|
|
$ |
1,656 |
|
Net increase in cash |
|
$ |
151,150 |
|
|
$ |
923,013 |
|
Operating
Activities
We
used $1,579,731 and $1,699,073 of cash in operating activities
during the three months ended December 31, 2021 and 2020,
respectively, principally to fund our operating losses.
Investing
Activities
We
used $3,009 and $58,990 of cash in investing activities during the
three months ended December 31, 2021 and 2020, respectively. Cash
used in both periods was to fund the purchase of
equipment.
Financing
Activities
Historically,
we have funded our operations primarily through the issuance of our
common stock.
Cash
provided by financing activities of $1,701,202 and $2,679,420 for
the three months ended December 31, 2021 and 2020, respectively, is
primarily related to proceeds received upon the exercise of
outstanding Warrants by the Warrant holders in the three months
ended December 31, 2021, as further described below, and issuance
of equity securities in the three months ended December 31,
2020.
In the three months ended December 31, 2021, we issued 384,447
shares of common stock related to exercises of warrants, including
380,447 shares of common stock issued upon exercise of 380,447
Series A Warrants and 4,000 shares of common stock issued upon
exercise of 8,000 Series B Warrants. In connection with such
exercises, in the three months ended December 31, 2021, we received
aggregate net proceeds of $1,721,018. For additional information
regarding the Series A Warrants and Series B Warrants, see Note
5—Stock Options and Warrants to the Unaudited Consolidated
Financial Statements.
ATM Offering
On
December 28, 2021, we entered into the Equity Distribution
Agreement with Maxim, as Agent, pursuant to which we may offer and
sell, from time to time, shares of our common stock through the
Agent in “at-the-market-offerings”, as defined in Rule 415 under
the Securities Act, having an aggregate offering price of up to
$20,000,000, subject to any applicable limits when using Form S-3.
The offer and sale of shares
will be made pursuant to a shelf registration statement on Form S-3
and the related prospectus (File No. 333-248531) initially filed by
us with the SEC on September 1, 2020, and declared effective by the
SEC on October 2, 2020, under the Securities Act. We are not
obligated to make any sales of shares of our common stock under the
Equity Distribution Agreement. As of December 31, 2021, no sales
had occurred under the Equity Distribution Agreement. During the
period from January 1, 2022 through February 4, 2022, we issued and
sold 4,860 shares of our common stock under the Equity Distribution
Agreement, raising net proceeds of $12,542.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results
of operations are based upon our financial statements that have
been prepared in accordance with generally accepted accounting
principles in the United States of America (“US GAAP”). The
preparation of financial statements in conformity with US GAAP
requires management to make estimates and assumptions that affect
the reported amounts of assets, liabilities, revenues and expenses,
and the disclosure of contingent assets and liabilities. US GAAP
provides the framework from which to make these estimates,
assumption and disclosures. We choose accounting policies within US
GAAP that management believes are appropriate to accurately and
fairly report our operating results and financial position in a
consistent manner. Management regularly assesses these policies in
light of current and forecasted economic conditions. See Note
1—Basis of Presentation and Summary of Significant Accounting
Policies of the Notes to the Unaudited Consolidated Financial
Statements for a summary of our accounting policies.
There were no significant and material changes in our critical
accounting policies and use of estimates during the three months
ended December 31, 2021, as compared to those disclosed in
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations—Critical Accounting Policies and Estimates”
in our Annual Report on Form 10-K for the fiscal year ended
September 30, 2021, filed with the SEC on December 22,
2021.
Item 3. Quantitative and Qualitative Disclosures About
Market Risk.
We
are a smaller reporting company as defined by Rule 12b-2 of the
Exchange Act and are not required to provide the information under
this item.
Item 4. Controls and Procedures
Disclosure
controls and procedures are controls and other procedures that are
designed to ensure that information required to be disclosed in our
periodic reports filed or submitted under the Exchange Act is
recorded, processed, summarized and reported within the time
periods specified in the rules and forms of the SEC, and that such
information is collected and communicated to management, including
our Chief Executive Officer and Chief Financial Officer, as
appropriate, to allow timely decisions regarding required
disclosure. Our Chief Executive Officer and Chief Financial Officer
are responsible for establishing and maintaining disclosure
controls and procedures for our Company. In designing and
evaluating our disclosure controls and procedures, management
recognizes that no matter how well conceived and operated,
disclosure controls and procedures can provide only reasonable, not
absolute, assurance that the objectives of the disclosure controls
and procedures are met.
Our
management, with the participation of our Chief Executive Officer
and Chief Financial Officer, carried out an evaluation of the
effectiveness of our “disclosure controls and procedures” (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the
end of the period covered by this Quarterly Report on Form 10-Q
(the “Evaluation Date”). Based upon that evaluation, our Chief
Executive Officer and Chief Financial Officer concluded that, as of
the Evaluation Date, our disclosure controls and procedures were
effective to provide reasonable assurance that information required
to be disclosed by us in the reports that we file or submit under
the Exchange Act (i) is recorded, processed, summarized and
reported, within the time periods specified in the SEC rules and
forms and (ii) is accumulated and communicated to our management,
including our Chief Executive Officer and Chief Financial Officer,
as appropriate to allow timely decisions regarding required
disclosures.
Changes
in Internal Control Over Financial Reporting
There
were no changes in our internal control over financial reporting
during the quarter ended December 31, 2021 that have materially
affected, or are reasonably likely to materially affect, our
internal control over financial reporting.
PART
II.
Item 1. Legal Proceedings
On
November 23, 2021, Next Vision, Inc. (the “Consultant”) filed a
complaint against the Company in the Superior Court of California,
County of San Diego Central Division (Case No.
37-2021-00049557-CU-BC-CTL) (the “Complaint”). The Complaint
alleges that the Company’s delay in issuing shares of the Company’s
common stock (the “Shares”) to the Consultant after receiving due
notice from the Consultant of its intent to exercise vested stock
options to acquire 70,000 Shares, as initially granted in 2018 (or,
as adjusted to account for the Company’s reverse stock split
effected on November 12, 2019, vested stock options to acquire
23,334 Shares) (the “Options”), which had previously been issued to
the Consultant as compensation for consulting services provided in
2018, breached express and implied contractual obligations to the
Consultant and resulted in the Company reporting an overstated
amount of income on the IRS Form 1099-B that was issued to the
Consultant for U.S. federal tax purposes. In addition, the
Complaint alleges that the 23,334 Shares issued to the Consultant
upon exercise of the Options improperly contained a six-month
restriction on resale and that such restriction prevented the
Consultant from selling the Shares at the desired time. The
Complaint seeks equitable relief requiring the Company to issue an
IRS Form 1099-NEC to reflect the correct amount of compensation.
The Complaint also seeks compensatory damages, including to recover
for alleged lost profits due to the alleged improper six-month
restriction on resale for the Shares, as well as punitive damages,
costs of suit, attorney’s fees, and interest. On January 20, 2022,
the Company filed its general denial and answer in which it raised
affirmative defenses and disputed the claims contained in the
Complaint.
We
believe the allegations set forth in the Complaint are without
merit and intend to defend vigorously against the allegations.
However, the Company is not able to predict the outcome, and there
is no assurance that the Company will be successful in its
defense.
From time to time, we may be subject to other legal proceedings and
claims in the ordinary course of business. The results of any
future litigation cannot be predicted with certainty, and
regardless of the outcome, litigation can have an adverse impact on
us because of defense and settlement costs, diversion of management
resources, and other factors.
Item 1A. Risk Factors
Except
as set forth below, there have been no material changes to our risk
factors from those disclosed in our Annual Report on Form 10-K
filed with the SEC on December 22, 2021.
A significant portion of our total outstanding shares of common
stock are eligible to be sold into the market in the near future,
including pursuant to Rule 144, which could cause the market price
of our common stock to drop significantly, even if our business is
doing well.
Sales
of a substantial number of shares of our common stock in the public
market could occur at any time. These sales, or the perception in
the market that the holders of a large number of shares intend to
sell shares, could reduce the market price of our common stock. We
have also registered all shares of common stock that are reserved
for issuance under the NuZee, Inc. 2019 Stock Incentive Plan and
all shares of common stock currently reserved for issuance under
the NuZee, Inc. 2013 Stock Incentive Plan. As a result, these
shares can be freely sold in the public market upon issuance,
subject to volume limitations applicable to affiliates and the
lock-up agreements described in our filings with the SEC. A sale
under Rule 144 or under any other exemption from the Securities
Act, if available, or pursuant to subsequent registrations of our
shares of common stock, may have a depressive effect upon the price
of our shares of common stock in any active market that may
develop. We believe that a significant portion of our total
outstanding shares of common stock may be sold in the public market
without restriction by non-affiliates pursuant to Rule
144.
We have also entered into the Equity Distribution Agreement with
Maxim, as Agent, pursuant to which we may offer and sell, from time
to time, shares of our common stock through the Agent in
“at-the-market-offerings”, as defined in Rule 415 under the
Securities Act, having an aggregate offering price of up to
$20,000,000, subject to any applicable limits when using Form S-3.
Sales of a substantial number of shares of common stock under the
Equity Distribution Agreement, or the perception that those sales
may occur, could cause the market price of our common stock to
decline.
Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds
None.
Item 6. Exhibits
EXHIBIT
NO. |
|
DESCRIPTION |
3.1 |
|
Articles of Incorporation of the
Company, dated July 15, 2011 (incorporated by reference to Exhibit
3.1 to the Company’s Registration Statement on Form S-1 filed on
September 6, 2011, SEC File Number 333-176684) |
3.2 |
|
Certificate of Amendment to Articles
of Incorporation of the Company, dated May 6, 2013 (incorporated by
reference to Exhibit 3.01(b) to the Company’s Current Report on
Form 8-K filed on April 25, 2013, SEC File Number
333-176684) |
3.3 |
|
Certificate of Amendment to Articles
of Incorporation of the Company, dated October 28, 2019
(incorporated by reference to Exhibit 3.1 to the Company’s Current
Report on Form 8-K filed on October 28, 2019, SEC File Number
000-55157) |
3.4 |
|
Second Amended and Restated Bylaws of
the Company, dated April 22, 2016 (incorporated by reference to
Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on
April 28, 2016, SEC File Number 000-55157) |
10.1 |
|
Equity Distribution Agreement by and
between the Company and Maxim Group LLC dated as of December 28,
2021 (incorporated by reference to Exhibit 1.1 to the Company’s
Current Report on Form 8-K filed on December 29, 2021, SEC File
Number 001-39338) |
10.2*† |
|
Form
of Stock Option Agreement under NuZee, Inc. 2013 Stock Incentive
Plan (Time-Based) |
10.3*† |
|
Form
of Stock Option Agreement under NuZee, Inc. 2013 Stock Incentive
Plan (Performance-Based) |
10.4*† |
|
Form
of Restricted Stock Award Agreement under the NuZee, Inc. 2013
Stock Incentive Plan |
31.1* |
|
Certification of Chief Executive Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 |
31.2* |
|
Certification of Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 |
32.1** |
|
Certification of Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2** |
|
Certification of Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 |
101.INS |
|
Inline
XBRL Instance Document*** |
101.SCH |
|
Inline
XBRL Taxonomy Extension Schema Document |
101.CAL |
|
Inline
XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF |
|
Inline
XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB |
|
Inline
XBRL Taxonomy Extension Label Linkbase Document |
101.PRE |
|
Inline
XBRL Taxonomy Extension Presentation Linkbase Document |
104 |
|
Cover
Page Interactive Data File (formatted in Inline XBRL and contained
in Exhibit 101) |
†
Indicates management contract or compensatory plan.
*
Filed herewith.
**
Furnished herewith.
***
The instance document does not appear in the interactive data file
because its XBRL tags are embedded within the inline XBRL
document.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of
the registrant and in the capacities and on the dates
indicated.
Date: |
February
11, 2022 |
|
NUZEE,
INC. |
|
|
|
|
|
|
|
|
By: |
/s/
Masateru Higashida |
|
|
|
|
Masateru
Higashida, Chief Executive Officer and President (Principal
Executive Officer), Secretary, Treasurer, and Director |
|
|
|
|
|
|
|
|
By: |
/s/
Patrick Shearer |
|
|
|
|
Patrick
Shearer, Chief Financial Officer (Principal Financial Officer and
Principal Accounting Officer) |
NuZee (NASDAQ:NUZE)
Historical Stock Chart
From Feb 2023 to Mar 2023
NuZee (NASDAQ:NUZE)
Historical Stock Chart
From Mar 2022 to Mar 2023